An official website of the United States government
2013 ACBS Landline-Cellphone Combined Prevalence Tables
TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line And Cell Phone Combined Sample, United States, 2013
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| California | 238 | 46.4 | 4.9 | (36.8 – 56.0) | 255 | 48.6 | 4.8 | (39.2 – 58.0) |
| Connecticut | 252 | 60.5 | 4.9 | (50.9 – 70.1) | 274 | 53.2 | 5.6 | (42.2 – 64.2) |
| Georgia | 144 | 43.3 | 5.8 | (31.9 – 54.7) | 154 | 41.0 | 5.8 | (29.6 – 52.4) |
| Hawaii | 189 | 47.9 | 5.9 | (36.3 – 59.5) | 193 | 46.9 | 5.8 | (35.5 – 58.3) |
| Indiana | 406 | 55.4 | 3.6 | (48.3 – 62.5) | 429 | 53.7 | 3.5 | (46.8 – 60.6) |
| Iowa | 262 | 45.0 | 5.5 | (34.2 – 55.8) | 269 | 43.6 | 5.3 | (33.2 – 54.0) |
| Maryland | 264 | 49.3 | 5.3 | (38.9 – 59.7) | 285 | 46.8 | 5.1 | (36.8 – 56.8) |
| Michigan | 654 | 59.4 | 2.9 | (53.7 – 65.1) | 702 | 56.0 | 2.9 | (50.3 – 61.7) |
| Mississippi | 264 | 45.8 | 5.4 | (35.2 – 56.4) | 270 | 45.6 | 5.3 | (35.2 – 56.0) |
| Missouri | 274 | 56.9 | 5.4 | (46.3 – 67.5) | 284 | 54.8 | 5.3 | (44.4 – 65.2) |
| Montana | 320 | 56.7 | 4.4 | (48.1 – 65.3) | 348 | 50.3 | 4.9 | (40.7 – 59.9) |
| Nebraska | 324 | 41.2 | 5.8 | (29.8 – 52.6) | 350 | 39.6 | 5.4 | (29.0 – 50.2) |
| Nevada | 137 | 57.1 | 6.7 | (44.0 – 70.2) | 161 | 56.2 | 6.8 | (42.9 – 69.5) |
| New Hampshire | 266 | 50.9 | 5.2 | (40.7 – 61.1) | 281 | 47.8 | 5.0 | (38.0 – 57.6) |
| New Jersey | 313 | 40.6 | 4.2 | (32.4 – 48.8) | 349 | 36.8 | 3.9 | (29.2 – 44.4) |
| New Mexico | 324 | 54.7 | 4.2 | (46.5 – 62.9) | 343 | 52.0 | 4.4 | (43.4 – 60.6) |
| New York | 133 | 40.5 | 6.2 | (28.3 – 52.7) | 136 | 42.1 | 6.2 | (29.9 – 54.3) |
| North Carolina | 125 | 53.0 | 7.1 | (39.1 – 66.9) | 140 | 54.8 | 6.5 | (42.1 – 67.5) |
| Ohio | 318 | 52.9 | 5.3 | (42.5 – 63.3) | 335 | 50.6 | 5.0 | (40.8 – 60.4) |
| Oklahoma | 258 | 43.4 | 4.7 | (34.2 – 52.6) | 264 | 45.8 | 4.6 | (36.8 – 54.8) |
| Oregon | 199 | 59.4 | 5.4 | (48.8 – 70.0) | 221 | 56.4 | 5.3 | (46.0 – 66.8) |
| Pennsylvania | 313 | 51.4 | 4.1 | (43.4 – 59.4) | 342 | 50.1 | 3.8 | (42.7 – 57.5) |
| Texas | 265 | 56.0 | 6.0 | (44.2 – 67.8) | 295 | 51.5 | 5.6 | (40.5 – 62.5) |
| Utah | 441 | 54.9 | 3.4 | (48.2 – 61.6) | 460 | 53.5 | 3.4 | (46.8 – 60.2) |
| Vermont | 237 | 61.0 | 6.1 | (49.0 – 73.0) | 246 | 63.4 | 5.6 | (52.4 – 74.4) |
| Washington | 367 | 55.0 | 3.9 | (47.4 – 62.6) | 374 | 57.2 | 3.9 | (49.6 – 64.8) |
| West Virginia | 187 | 52.3 | 4.6 | (43.3 – 61.3) | 189 | 52.8 | 4.7 | (43.6 – 62.0) |
| Wisconsin | 265 | 55.0 | 5.7 | (43.8 – 66.2) | 265 | 56.4 | 5.7 | (45.2 – 67.6) |
| Puerto Rico | 334 | 40.9 | 4.1 | (32.9 – 48.9) | 402 | 36.9 | 3.6 | (29.8 – 44.0) |
| 28 state total | 8,073 | 50.1 | 1.4 | (47.4 – 52.8) | 8,616 | 49.3 | 1.3 | (46.8 – 51.8) |
| Median | 52.9 | 50.6 | ||||||
| Range | 40.5-61.0 | 36.8-63.4 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval